Develops drugs for rare genetic diseases.
Apr 2026Revenue $980K/yrExpenses $37.4M/yr
Fell below break-even Aug 2017Cash runway ≈ 11 months from Apr 2026
Figures by year
When will Rafael Holdings be profitable again?
Its expenses passed its revenue in Aug 2017. In the 12 months to Apr 2026, revenue was $980K and expenses $37.4M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jul 2025 | $917K | $30.1M | −$29.2M |
| Jul 2024 | $637K | $103M | −$103M |
| Jul 2023 | $279K | $15.3M | −$15.0M |
| Jul 2022 | $410K | $60.9M | −$60.5M |
| Jul 2021 | $802K | $29.0M | −$28.2M |
| Jul 2020 | $4.91M | $13.4M | −$8.46M |
| Jul 2019 | $4.93M | $11.6M | −$6.70M |
| Jul 2018 | $4.37M | $8.21M | −$3.84M |
| Jul 2017 | $5.62M | $5.40M | $221K |
| Jul 2016 | $5.59M | $4.40M | $1.19M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.